Histogen Inc. Net Change in Cash
Histogen Inc. reported Net Change in Cash of -$7.64 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2023-11-09
- Histogen Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was -$2.55M.
- Histogen Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2022-03-31 was -$837.00K, a 105.59% decline year-over-year.
- Histogen Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2021-03-31 was $14.98M.
- Histogen Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2020-03-31 was -$1.31M, a 117.20% decline year-over-year.
- Histogen Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$6.58M, a 153.41% decline from fiscal 2021.
- Histogen Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2021 was $12.31M, a 162.07% increase from fiscal 2020.
- Histogen Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2020 was $4.70M.
- Histogen Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2019 was -$962.00K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2023-09-30 | -$7.64M 10-Q · filed 2023-11-09 | ||||||
| 2023-06-30 | -$4.95M 10-Q · filed 2023-08-10 | ||||||
| 2023-03-31 | -$2.55M 10-Q · filed 2023-05-11 | ||||||
| 2022-12-31 | -$6.58M 10-K · filed 2023-03-09 | ||||||
| 2022-09-30 | -$4.13M 10-Q · filed 2023-11-09 | ||||||
| 2022-06-30 | -$6.09M 10-Q · filed 2023-08-10 | ||||||
| 2022-03-31 | -$837.00K 10-Q · filed 2023-05-11 | ||||||
| 2021-12-31 | $12.31M 10-K · filed 2023-03-09 | ||||||
| 2021-09-30 | $12.44M 10-Q · filed 2022-11-10 | ||||||
| 2021-06-30 | $16.38M 10-Q · filed 2022-08-11 | ||||||
| 2021-03-31 | $14.98M 10-Q · filed 2022-05-12 | ||||||
| 2020-12-31 | $4.70M 10-K · filed 2022-03-10 | ||||||
| 2020-09-30 | $4.83M 10-Q · filed 2021-11-10 | ||||||
| 2020-06-30 | $8.58M 10-Q · filed 2021-08-11 | ||||||
| 2020-03-31 | -$1.31M 10-Q · filed 2021-05-13 | -$2.65M 10-Q · filed 2020-05-01 | |||||
| 2019-12-31 | -$962.00K 10-K · filed 2021-03-11 | $9.14M 10-K · filed 2020-03-11 | |||||
| 2019-09-30 | $731.00K 10-Q · filed 2020-11-10 | $6.75M 10-Q · filed 2019-11-05 | |||||
| 2019-06-30 | $3.23M 10-Q · filed 2020-08-13 | ||||||
| 2019-03-31 | $7.60M 10-Q · filed 2020-05-01 | ||||||
| 2018-12-31 | -$4.51M 10-K · filed 2020-03-11 | ||||||
| 2018-09-30 | -$2.77M 10-Q · filed 2019-11-05 | ||||||
| 2017-12-31 | -$42.00M 10-K · filed 2020-03-11 |